Clinical, angiographic profile and percutaneous endovascular management of Takayasu's arteritis - A single centre

H S Natraj Setty1, Murali Rao1, K H Srinivas1

  • 1Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India.

Insights

Takayasu

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Rheumatology

Background:

  • Takayasu's arteritis is a rare, chronic inflammatory vasculitis affecting the aorta and its major branches.
  • While more common in Asia, it has a worldwide distribution with varied presentations.
  • The condition can manifest with diverse vascular involvement patterns and clinical symptoms.

Purpose of the Study:

  • To evaluate the clinical and angiographic characteristics of Takayasu's arteritis.
  • To assess the effectiveness of percutaneous endovascular management strategies.

Main Methods:

  • A prospective study of 50 consecutive Takayasu's arteritis patients from January 2010 to April 2016.
  • Detailed analysis of clinical presentations and angiographic findings.
  • Evaluation of treatment outcomes for endovascular and medical management.

Main Results:

  • The study analyzed 50 patients, predominantly female (86%), with an average age of 26.92 years.
  • Common symptoms included claudication (74%), musculoskeletal pain (48%), and fatigue (46%).
  • Absent pulses (80%) and blood pressure differences (80%) were frequent findings; angiographic type I was most common (40%).
  • Percutaneous transluminal angioplasty was the primary treatment in 66% of patients.

Conclusions:

  • Takayasu's arteritis primarily affects women and presents with a wide spectrum of symptoms, from asymptomatic findings to severe neurological impairment.
  • It is a significant cause of renovascular hypertension, with angiography being the gold standard for diagnosis.
  • Percutaneous transluminal angioplasty with stenting is a valuable treatment option for selected Takayasu's arteritis patients.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
503
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
435
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
603
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
373
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
391